Preclinical studies have demonstrated that GLP-1 receptor agonists reduce neuroinflammation, reduce tau phosphorylation, reduce amyloid deposition, increase synaptic function, and improve memory formation
Natural food formulations can stimulate GLP-1, and a number are in development
SGLT-2 accounts for the majority of glucose reabsorption in the kidney and has, thus, surfaced as a therapeutic target for the treatment of T2DM
GLP-2 , on the other hand, is the guardian of the gut lining
Mounjaro: Mounjaro is a dual-action drug that contains tirzepatide, which is approved for the treatment of Type 2 diabetes
Acid reflux, burping, and bloating As Mounjaro slows stomach emptying, some people notice increased pressure in the stomach